With a total investment of 30 million yuan and 14 research institutes comprising 30 research teams, the project will be implemented for two years, and through the implementation of this ‘seed program’, pre-research work will be done for the ‘China Microbiological Group Project’ . Head of this program is LIU Shuangjiang, director of the Institute of Microbiology, CAS., and topics are human metabolic diseases and the regulation of gut microbes by Chinese herbal medicines.

China Bio news release, January 16, 2018